Invention Grant
- Patent Title: Pharmaceutical formulation containing gelling agent
-
Application No.: US13905931Application Date: 2013-05-30
-
Publication No.: US08529948B1Publication Date: 2013-09-10
- Inventor: Curtis Wright , Benjamin Oshlack , Christopher Breder
- Applicant: Purdue Pharma L.P.
- Applicant Address: US CT Stamford US NJ Totowa US NC Wilson
- Assignee: Purdue Pharma L.P.,The P.F. Laboratories, Inc.,Purdue Pharmaceuticals L.P.
- Current Assignee: Purdue Pharma L.P.,The P.F. Laboratories, Inc.,Purdue Pharmaceuticals L.P.
- Current Assignee Address: US CT Stamford US NJ Totowa US NC Wilson
- Agency: Lowenstein Sandler LLP
- Main IPC: A61K9/20
- IPC: A61K9/20

Abstract:
Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.
Public/Granted literature
- US20130261145A1 PHARMACEUTICAL FORMULATION CONTAINING GELLING AGENT Public/Granted day:2013-10-03
Information query